André Ilbawi
- Oncology top 5%
- Global Cancer Incidence and Screening 32
- Colorectal Cancer Screening and Detection 8
- Economics and Econometrics top 2%
- Economic and Financial Impacts of Cancer 22
- Health Systems, Economic Evaluations, Quality of Life 16
-
- Global Health and Surgery 6
- Cancer Research top 10%
-
- Advances in Oncology and Radiotherapy 11
-
- Childhood Cancer Survivors' Quality of Life 8
-
- Cervical Cancer and HPV Research 6
- Co-authors
- Benjamin O. AndersonDario TrapaniFelipe RoitbergRachel RieraRafael Leite PachecoFreddie BrayÂngela Maria BagattiniDaniela Vianna Pachito
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
André Ilbawi
58 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Oncology 976
- Economics and Econometrics 433
- Public Health, Environmental and Occupational Health 402
- Cancer Research 180
- Radiology, Nuclear Medicine and Imaging 263
Countries citing papers authored by André Ilbawi
This map shows the geographic impact of André Ilbawi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Ilbawi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Ilbawi more than expected).
Fields of papers citing papers by André Ilbawi
This network shows the impact of papers produced by André Ilbawi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Ilbawi. The network helps show where André Ilbawi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside André Ilbawi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 8 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 8 | |
| 9 | 2022 | 11 | |
| 10 | 2022 | 84 | |
| 11 | 2021 | 28 | |
| 12 | 2020 | 6 | |
| 13 | 2019 | 17 | |
| 14 | 2018 | 105 | |
| 15 | 2018 | 15 | |
| 16 | 2018 | 120 | |
| 17 | 2018 | 28 | |
| 18 | 2018 | 17 | |
| 19 | 2015 | 6 | |
| 20 | 2007 | 11 |
About André Ilbawi
André Ilbawi is a scholar working on Oncology, Economics and Econometrics, Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Radiology, Nuclear Medicine and Imaging, having authored 61 papers that have together received 2.2k indexed citations. Recurring topics across this work include Global Cancer Incidence and Screening (32 papers), Economic and Financial Impacts of Cancer (22 papers), Health Systems, Economic Evaluations, Quality of Life (16 papers), Advances in Oncology and Radiotherapy (11 papers), Childhood Cancer Survivors' Quality of Life (8 papers), Colorectal Cancer Screening and Detection (8 papers), Cervical Cancer and HPV Research (6 papers) and Global Health and Surgery (6 papers). The work is most often cited by research in Oncology (976 citations), Economics and Econometrics (433 citations), Public Health, Environmental and Occupational Health (402 citations), Cancer Research (180 citations) and Radiology, Nuclear Medicine and Imaging (263 citations). André Ilbawi has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Benjamin O. Anderson, Dario Trapani, Felipe Roitberg, Rachel Riera, Rafael Leite Pacheco, Freddie Bray, Ângela Maria Bagattini, Daniela Vianna Pachito, Giuseppe Curigliano and Filip Meheus. Their work appears in journals such as The Lancet Oncology, JCO Global Oncology, ESMO Open, The Lancet Global Health and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.